Teva Pharmaceuticals Financial Market Data
| Last Close 04-Sep-2008 |
$47.92 |
Price/ Sales Ratio |
2.97 |
| 52-Week High |
$50.00 |
Price/ Book Ratio |
2.04 |
| 52-Week Low |
$40.37 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
0.3 |
Price/ Cash Flow Ratio |
15.42 |
| Market Cap (mil.) |
-- |
Return on Assets |
8.9% |
| Shares Outstanding (mil.) |
-- |
Return on Equity |
15.7% |
| Dividend Rate |
0.51 |
Current Ratio |
1.84 |
| Dividend Yield |
51.0% |
Long-Term Debt/Equity |
0.39 |
| # of Institutional Holders |
748 |
% Owned by Institutions |
57.0% |
| Latest Short Interest Ratio |
4.25 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
11.9% |
96.0% |
273.5% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
36.9% |
146.2% |
387.6% |
This data is provided as per license from EDGAR Online
